Maverick Capital, Ltd. 13D and 13G filings for Verona Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | Verona Pharma plc VRNA | Maverick Capital, Ltd. | 25,028,128 3.800% | -8,699,656 (-25.79%) | Filing |
| 2024-11-14 4:31 pm Purchase | 2024-09-30 | 13G | Verona Pharma plc VRNA | Maverick Capital, Ltd. | 33,727,784 5.200% | 33,727,784 (New Position) | Filing |